Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Yun Fan
Neng-ming Lin
Sheng-lin Ma
Lü-hong Luo
Luo Fang
Zhi-yu Huang
Hai-feng Yu
Feng-qin Wu
机构：
[1] Zhejiang Cancer Hospital,Department of Chemo
[2] Laboratory of Clinical Pharmacy,therapy Center
[3] Zhejiang Cancer Hospital,undefined
来源：
Acta Pharmacologica Sinica | 2010年 / 31卷
关键词：
gemcitabine; cisplatin; non small cell lung cancer (NSCLC); pharmacodynamics; pharmacokinetics; combined drug therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：746 / 752
页数：6
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [2] Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: A phase II study
    Bretti, S
    Manzin, E
    Loddo, C
    Berruti, A
    Bombaci, S
    Vellani, G
    Celano, A
    [J]. ANTICANCER RESEARCH, 2002, 22 (05) : 3039 - 3043
  • [3] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [4] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [5] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
  • [6] Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Mazzanti, P
    Massacesi, C
    Rocchi, MBL
    Mattioli, R
    Lippe, P
    Trivisonne, R
    Buzzi, F
    De Signoribus, G
    Tuveri, G
    Rossi, G
    Di Lullo, L
    Sturba, F
    Morale, D
    Catanzani, S
    Pilone, A
    Bonsignori, M
    Battelli, T
    [J]. LUNG CANCER, 2003, 41 (01) : 81 - 89
  • [7] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    [J]. LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [8] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Welte, T
    Müller, T
    Scholtze, J
    Graeven, U
    Jasiewicz, Y
    Edler, L
    Hossfeld, DK
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 654 - 660
  • [9] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    [J]. LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [10] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
12345